Gaspar G - Search Results

1

HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018.

Pérez-Latorre L, Berenguer J, Micán R, Montero M, Cifuentes C, Puig T, Sanz J, Ferrero OL, De La Fuente B, Rodríguez C, Reus S, Hernández-Quero J, Gaspar G, Pérez-Martínez L, García C, Force L, Veloso S, De Miguel M, Jarrín I, González-García J; GeSIDA 8514 Study Group. Pérez-Latorre L, et al. Among authors: gaspar g. Euro Surveill. 2021 Jun;26(25):2000236. doi: 10.2807/1560-7917.ES.2021.26.25.2000236. Euro Surveill. 2021. PMID: 34169818 Free PMC article.

2

Patients' perception and effectiveness of a treatment containing enfuvirtide when used in HIV-infected patients without very advanced disease.

Pulido F, Del Pozo MA, Fernández-Guerrero M, Moreno A, Oteo JA, Flores J, Pedrol E, Torres R, Padilla B, Téllez MJ, García J, González-García J; ESPPE Study Group. Pulido F, et al. HIV Clin Trials. 2008 Mar-Apr;9(2):83-90. doi: 10.1310/hct0902-83. HIV Clin Trials. 2008. PMID: 18474493

3

Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis.

Velasco M, Castilla V, Sanz J, Gaspar G, Condes E, Barros C, Cervero M, Torres R, Guijarro C; COMESEM Cohort. Velasco M, et al. Among authors: gaspar g. J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):148-52. doi: 10.1097/QAI.0b013e31819367e7. J Acquir Immune Defic Syndr. 2009. PMID: 19131895

4

Prevalence of HLA-B*5701 in HIV-infected patients in Spain (results of the EPI Study).

Arrizabalaga J, Rodriguez-Alcántara F, Castañer JL, Ocampo A, Podzamczer D, Pulido F, Riera M, Sanz J, Pascual-Bernaldez M, Dal-Re R; EPI109839 Study Group. Arrizabalaga J, et al. HIV Clin Trials. 2009 Jan-Feb;10(1):48-51. doi: 10.1310/hct1001-048. HIV Clin Trials. 2009. PMID: 19362996

5

Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: results from a study on patient and physician perceptions.

Cabrero E, Griffa L, Burgos A; HIV Body Physical Changes Study Group. Cabrero E, et al. AIDS Patient Care STDS. 2010 Jan;24(1):5-13. doi: 10.1089/apc.2009.0191. AIDS Patient Care STDS. 2010. PMID: 20095903 Free article.

6

[Current situation of human immunodeficiency virus type 2 and Human T lymphotropic virus in Spain].

Treviño A, Soriano V; Grupo Español para el Estudio del VIH-2 y HTLV. Treviño A, et al. Enferm Infecc Microbiol Clin. 2010 Aug-Sep;28(7):442-5. doi: 10.1016/j.eimc.2010.04.001. Epub 2010 Jun 8. Enferm Infecc Microbiol Clin. 2010. PMID: 20570417 Spanish.

7

Drug resistance mutations in patients infected with HIV-2 living in Spain.

Treviño A, de Mendoza C, Caballero E, Rodríguez C, Parra P, Benito R, Cabezas T, Roc L, Aguilera A, Soriano V; HIV-2 Spanish Study Group. Treviño A, et al. J Antimicrob Chemother. 2011 Jul;66(7):1484-8. doi: 10.1093/jac/dkr164. Epub 2011 May 10. J Antimicrob Chemother. 2011. PMID: 21558334

8

[Infection by HIV-2, HTLV and new human retroviruses in Spain].

Treviño A, Soriano V; Grupo Español para el Estudio del VIH-2/HTLV. Treviño A, et al. Med Clin (Barc). 2012 May 5;138(12):541-4. doi: 10.1016/j.medcli.2011.03.003. Epub 2011 May 11. Med Clin (Barc). 2012. PMID: 21565368 Spanish. No abstract available.

9

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus.

Berenguer J, von Wichmann MA, Quereda C, Miralles P, Mallolas J, López-Aldeguer J, Alvarez-Pellicer J, De Miguel J, Crespo M, Guardiola JM, Tellez MJ, Galindo MJ, Arponen S, Barquilla E, Bellón JM, González-García J; GESIDA 36/03 and 50/06 Study Groups. Berenguer J, et al. J Antimicrob Chemother. 2011 Dec;66(12):2843-9. doi: 10.1093/jac/dkr362. Epub 2011 Sep 29. J Antimicrob Chemother. 2011. PMID: 21965432

10

Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms.

Treviño A, Lopez M, Vispo E, Aguilera A, Ramos JM, Benito R, Roc L, Eiros JM, de Mendoza C, Soriano V; HTLV Spanish Study Group. Treviño A, et al. Clin Infect Dis. 2012 Jul;55(1):e1-4. doi: 10.1093/cid/cis343. Epub 2012 Mar 28. Clin Infect Dis. 2012. PMID: 22460962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page